Changing Cycle Lengths in State-Transition Models

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Medical decision making

• Publication date

  2016-07-01

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1177/0272989X16656165PMID 27369084PMCID PMC5045797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Theoretical Foundations and Practical Applications of Within-Cycle Correction Methods

  2016cited by this paper
• Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States

  2015cited by this paper
• Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States.

  2013cited by this paper
• Optimal Policies for Reducing Unnecessary Follow-Up Mammography Exams in Breast Cancer Diagnosis

  2013cited by this paper
• Calibrating Models in Economic Evaluation

  2012cited by this paper
• Rates and Probabilities in Economic Modelling

  2012cited by this paper
• State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3.

  2012cited by this paper
• State-Transition Modeling

  2012cited by this paper
• New Protease Inhibitors for the Treatment of Chronic Hepatitis C

  2012cited by this paper
• Roots of Stochastic Matrices and Fractional Matrix Powers

  2011cited by this paper
• Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?

  2011cited by this paper
• Optimal Breast Biopsy Decision-Making Based on Mammographic Features and Demographic Factors

  2010cited by this paper
• Introduction to linear Algebra

  2010cited by this paper
• Rates and probabilities in economic modelling: transformation, translation and appropriate application.

  2007cited by this paper
• Decision Modelling for Health Economic Evaluation

  2006cited by this paper
• Estimation of Markov Chain Transition Probabilities and Rates from Fully and Partially Observed Data: Uncertainty Propagation, Evidence Synthesis, and Model Calibration

  2005cited by this paper
• Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

  2005cited by this paper
• Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients.

  2004cited by this paper
• When should decision-analytic modeling be used in the economic evaluation of health care?

  2003cited by this paper
• Estimation of the transition matrix of a discrete-time Markov chain.

  2002cited by this paper
• Economic Evaluation in Health Care: Merging Theory with Practice

  2002cited by this paper
• Finding Generators for Markov Chains via Empirical Transition Matrices, with Applications to Credit Ratings

  2001influential reference
• Cost-effectiveness of screening for colorectal cancer in the general population.

  2000cited by this paper
• Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

  1997cited by this paper
• Modelling the Cost Effectiveness of Lamivudine/Zidovudine Combination Therapy in HIV Infection

  1997cited by this paper
• Primer on Medical Decision Analysis: Part 1—Getting Started

  1997cited by this paper
• Determining Transition Probabilities

  1994cited by this paper
• Markov Models in Medical Decision Making

  1993cited by this paper
• Applied Probability and Queues

  1987cited by this paper
• Microcomputer Aids to Medical Decision Making

  1983cited by this paper
• The Markov Process in Medical Prognosis

  1983cited by this paper
• The Representation of Social Processes by Markov Models

  1976influential reference

• Cost-utility analysis of sotagliflozin for heart failure patients with diabetes in China.

  2025cites this paper
• Cost-effectiveness of the rural lifestyle eating and activity program (Rural LEAP)

  2025cites this paper
• Evaluating Semi-Markov Processes and Other Epidemiological Time-to-Event Models by Computing Disease Sojourn Density as Partial Differential Equations

  2025cites this paper
• Modeling cost-effectiveness analysis of treatment sequencing

  2025cites this paper
• Changing Time Representation in Microsimulation Models

  2025cites this paper
• Simplified Methods for Modelling Dependent Parameters in Health Economic Evaluations: A Tutorial

  2024cites this paper
• Comparative pharmacoeconomic analysis of rituximab and traditional tacrolimus regimens in membranous nephropathy in China

  2024cites this paper
• Computing pth root of a transition matrix with a deep unsupervised learning approach

  2024cites this paper
• Examining chronic kidney disease screening frequency among diabetics: a POMDP approach

  2024cites this paper
• Cost saving analysis of prediabetes intervention modalities in comparison with inaction using Markov state transition model—A multiregional case study

  2024cites this paper
• Quantifying the benefits of increasing decision-making frequency for health applications with regular decision epochs

  2024cites this paper
• Cost-Effectiveness of Dapagliflozin vs Empagliflozin for Treating Heart Failure With Reduced Ejection Fraction in the United States.

  2023cites this paper
• Estimating transition probabilities between health states using US longitudinal survey data

  2022cites this paper
• Cost-Effectiveness of Vonoprazan-Based and Rifabutin-Based vs Other Regimens as First-Line Treatment of Helicobacter pylori Infection in the United States

  2022cites this paper
• Progression of frailty as measured by a cumulative deficit index: a systematic review.

  2022cites this paper
• Maximum likelihood estimation for nonembeddable Markov chains when the cycle length is shorter than the data observation interval

  2022cites this paper
• Comparative cost-effectiveness of trabeculectomy versus MicroShunt in the United States Medicare system.

  2022cites this paper
• Cost-effectiveness of internet-supported cognitive behavioral therapy for university students with anxiety symptoms: A Markov-model analysis

  2022cites this paper
• Fully Covered Self-Expanding Stents are Cost-Effective at Remediating Biliary Strictures in Patients with Chronic Pancreatitis.

  2022cites this paper
• Cost Utility of Schlemm’s Canal Microstent Injection With Cataract Surgery for Open-angle Glaucoma in the US Medicare System

  2022cites this paper
• Treatment for Severe Lupus Nephritis: A Cost-Effectiveness Analysis in China

  2021cites this paper
• An Analytics‐Driven Approach for Optimal Individualized Diabetes Screening

  2021cites this paper
• Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals

  2021cites this paper
• Optimizing diabetes screening frequencies for at-risk groups

  2021cites this paper
• Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression

  2021cites this paper
• Projecting the Long-term Clinical Value of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy in the United States: An Assessment of Net Health Benefit.

  2021cites this paper
• Thrombectomy is a cost-saving procedure up to 24 h after onset

  2021cites this paper
• Modeling the coronavirus disease 2019 pandemic: A comprehensive guide of infectious disease and decision-analytic models

  2020cites this paper
• A Regression-Based Procedure for Markov Transition Probability Estimation in Land Change Modeling

  2020influential citation
• The STarT Back stratified care model for non-specific low back pain: a model-based evaluation of long-term cost-effectiveness.

  2020cites this paper
• Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers

  2020cites this paper
• Projecting effectiveness after ending a randomized controlled trial: a two-state Markov microsimulation model

  2020cites this paper
• Comparison of Decision Modeling Approaches for Health Technology and Policy Evaluation

  2020influential citation
• Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis

  2020cites this paper
• Cost-effectiveness model of abiraterone plus prednisone, cabazitaxel plus prednisone and enzalutamide for visceral metastatic castration resistant prostate cancer therapy after docetaxel therapy resistance

  2019cites this paper
• Estimating Long-Term Drinking Patterns for People with Lifetime Alcohol Use Disorder

  2019cites this paper
• Alternative Conversion Methods for Transition Probabilities in State-Transition Models: Validity and Impact on Comparative Effectiveness and Cost-Effectiveness

  2019cites this paper
• Comparing Markov and non-Markov alternatives for cost-effectiveness analysis: Insights from a cervical cancer case

  2019cites this paper
• Evaluation of Markov Models with Discontinuities

  2019cites this paper
• COST EFFECTIVENESS ANALYSIS OF ENZALUTAMIDE, ABIRATERONE PLUS PREDNISONE AND CABAZITAXEL PLUS PREDINSONE FOR THE TREATMENT OF VISCERAL METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) AFTER DOCETAXEL THERAPY

  2018influential citation
• Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients.

  2018cites this paper
• An Exploratory Cost-Effectiveness Analysis of the Connected Health Intervention to Improve Care for People with Dementia: A Simulation Analysis

  2018cites this paper
• Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays

  2018cites this paper
• Cost-effectiveness analysis with new models of artificial intelligence. Medical applications

  2018cites this paper
• Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview

  2017cites this paper
• Unified Method for Markov Chain Transition Model Estimation Using Incomplete Survey Data

  2017influential citation
• Adding Events to a Markov Model Using DICE Simulation

  2017cites this paper
• Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review

  2017cites this paper